| No. |
Chromosome Location |
Chromatin state |
Cell line |
Tissue |
| 1 |
chr6:14034800-14038400 |
Enhancers |
IMR90 fetal lung fibroblasts Cell Line |
lung
|
| 2 |
chr6:14036800-14039400 |
Weak transcription |
H1 Derived Mesenchymal Stem Cells |
ES cell derived
|
| 3 |
chr6:14037200-14038200 |
Enhancers |
Primary monocytes fromperipheralblood |
blood
|
| 4 |
chr6:14037200-14038200 |
Enhancers |
Monocytes-CD14+_RO01746 |
blood
|
| 5 |
chr6:14037400-14038200 |
Enhancers |
Foreskin Fibroblast Primary Cells skin02 |
Skin
|
| 6 |
chr6:14037400-14038200 |
Enhancers |
NHEK |
skin
|
| 7 |
chr6:14037400-14038400 |
Flanking Active TSS |
Mesenchymal Stem Cell Derived Adipocyte Cultured Cells |
ES cell derived
|
| 8 |
chr6:14037400-14039000 |
Enhancers |
Primary hematopoietic stem cells G-CSF-mobilized Female |
--
|
| 9 |
chr6:14037600-14038200 |
Flanking Active TSS |
Adipose Derived Mesenchymal Stem Cell Cultured Cells |
ES cell derived
|
| 10 |
chr6:14037600-14038200 |
Flanking Active TSS |
Primary hematopoietic stem cells G-CSF-mobilized Male |
--
|
| 11 |
chr6:14037600-14040400 |
Enhancers |
Fetal Muscle Leg |
muscle
|
| 12 |
chr6:14037600-14040400 |
Enhancers |
K562 |
blood
|
| 13 |
chr6:14037800-14038200 |
Flanking Active TSS |
Bone Marrow Derived Cultured Mesenchymal Stem Cells |
Bone marrow
|
| 14 |
chr6:14037800-14038200 |
Enhancers |
Breast variant Human Mammary Epithelial Cells (vHMEC) |
Breast
|
| 15 |
chr6:14037800-14038200 |
Enhancers |
Primary hematopoietic stem cells |
blood
|
| 16 |
chr6:14037800-14038200 |
Flanking Active TSS |
Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells |
embryonic stem cell
|
| 17 |
chr6:14037800-14038200 |
Flanking Active TSS |
Muscle Satellite Cultured Cells |
--
|
| 18 |
chr6:14037800-14038200 |
Flanking Active TSS |
Foreskin Fibroblast Primary Cells skin01 |
Skin
|
| 19 |
chr6:14037800-14038200 |
Enhancers |
Foreskin Keratinocyte Primary Cells skin02 |
Skin
|
| 20 |
chr6:14037800-14038200 |
Flanking Active TSS |
Adipose Nuclei |
Adipose
|
| 21 |
chr6:14037800-14038200 |
Enhancers |
Placenta |
Placenta
|
| 22 |
chr6:14037800-14038200 |
Active TSS |
Hela-S3 |
cervix
|
| 23 |
chr6:14037800-14038200 |
Enhancers |
HMEC |
breast
|
| 24 |
chr6:14037800-14038200 |
Flanking Active TSS |
HSMM |
muscle
|
| 25 |
chr6:14037800-14038200 |
Flanking Active TSS |
HSMMtube |
muscle
|
| 26 |
chr6:14037800-14038200 |
Flanking Active TSS |
NHDF-Ad |
bronchial
|
| 27 |
chr6:14037800-14038200 |
Flanking Active TSS |
NHLF |
lung
|
| 28 |
chr6:14037800-14038200 |
Flanking Active TSS |
Osteobl |
bone
|
| 29 |
chr6:14037800-14040200 |
Enhancers |
Fetal Stomach |
stomach
|
| 30 |
chr6:14038000-14038200 |
Enhancers |
H1 BMP4 Derived Mesendoderm Cultured Cells |
ES cell derived
|
| 31 |
chr6:14038000-14038200 |
Enhancers |
H1 BMP4 Derived Trophoblast Cultured Cells |
ES cell derived
|
| 32 |
chr6:14038000-14038200 |
Enhancers |
H9 Cell Line |
embryonic stem cell
|
| 33 |
chr6:14038000-14038200 |
Enhancers |
HUES48 Cell Line |
embryonic stem cell
|
| 34 |
chr6:14038000-14038200 |
Enhancers |
HUES64 Cell Line |
embryonic stem cell
|
| 35 |
chr6:14038000-14038200 |
Enhancers |
iPS DF 19.11 Cell Line |
embryonic stem cell
|
| 36 |
chr6:14038000-14038200 |
Enhancers |
ES-UCSF4 Cell Line |
embryonic stem cell
|
| 37 |
chr6:14038000-14038200 |
Enhancers |
Foreskin Melanocyte Primary Cells skin01 |
Skin
|
| 38 |
chr6:14038000-14038200 |
Bivalent Enhancer |
Aorta |
Aorta
|
| 39 |
chr6:14038000-14038200 |
Enhancers |
NH-A |
brain
|
| 40 |
chr6:14038000-14039200 |
Enhancers |
GM12878-XiMat |
blood
|
